Learn more

EISAI LONDON RES LAB LTD

Overview
  • Total Patents
    66
About

EISAI LONDON RES LAB LTD has a total of 66 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are UROGENE, ZELTIA S A and MEDCO RES INC.

Patent filings in countries

World map showing EISAI LONDON RES LAB LTDs patent filings in countries

Patent filings per year

Chart showing EISAI LONDON RES LAB LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Taylor Joanne 6
#2 Khan Afzal 4
#3 Graczyk Piotr Pawel 3
#4 Bhatia Gurpreet Singh 3
#5 Farthing Christopher Neil 2
#6 Dimopoulos Paschalis 2
#7 Kline Adam 2
#8 Lucas Fiona Ralitsa 2
#9 Turner Laura 2
#10 Graczyk Piotr 2

Latest patents

Publication Filing date Title
GB0915893D0 Methods of screening for agents to treat Alzheimer's disease
GB0912777D0 Fused aminodihydropyrimidone derivatives
GB0912778D0 Fused aminodihydro-oxazine derivatives
GB0909575D0 Method of screening for agents to treat alzheimer's disease
GB0900262D0 Assay
GB0900261D0 Assay
GB0821624D0 Assay
GB0816956D0 Method of screening for agents to treat alzheimer's disease
GB0815224D0 Screening assay
GB0814364D0 Diazaindole derivatives and their use in the inhibition of c-Jun N-terminal kinase
GB0812779D0 Screening for agents for the treatment of Alzheimers Disease
GB0812780D0 Methods of screening for agents to treat Alzheimer's disease
GB0702266D0 7-Azaindoe derivatives
GB0702260D0 7-azaindole derivatives
GB0702265D0 7-Azaindole derivatives
GB0702259D0 7-azaindole derivatives
GB0700655D0 Targets for disease therapy
GB0700643D0 Targets for disease therapy
GB0700650D0 Targets for disease therapy
GB0700647D0 Targets for disease therapy